GGrantIndex
← Leaderboards

Talis Biomedical Corporation

Chicago, IL

Compare ↔
$6,029,839
Total funding
3
Grants

Funding over time

peak $1.3M · FY2011–22
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$6,029,839 · 3

By mechanism

R01$5,686,309 · 1
R43$343,530 · 2

Investigators at Talis Biomedical Corporation

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Betty B Wu$2,219,0761 gr2Hedia Maamar$1,178,8481 gr3Martin Goldberg$1,178,8481 gr4Kyle Andrew Tipton$1,109,5381 gr

All-Time

Most funded here, all years

1Betty B Wu$2,219,0761 gr2Hedia Maamar$1,178,8481 gr3Martin Goldberg$1,178,8481 gr4Kyle Andrew Tipton$1,109,5381 gr5Liang Li$256,8402 gr6Feng Shen$86,6911 gr

Largest grants

Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,251,580
R01 · FY2018 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,109,538
R01 · FY2021 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,109,538
R01 · FY2022 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,109,538
R01 · FY2020 · AI
Diagnostics via Rapid Enrichment, Identification, and Phenotypic Antibiotic Susceptibility Testing of Pathogens from Blood.$1,106,115
R01 · FY2019 · AI
SlipChip for Target Enrichment for Next-Gen Sequencing by Multiplexed PCR$173,381
R43 · FY2011 · HG
Testing Feasibility of SlipChip Workflow for Membrane Protein Crystallization$170,149
R43 · FY2011 · GM